Used in research for its potential anticancer properties, particularly in targeting Bcl-2 family proteins that regulate apoptosis. Shows activity against various cancer cell lines, including leukemia, lymphoma, and solid tumors. Investigated for its ability to overcome resistance to conventional chemotherapy by restoring apoptotic pathways. Also studied in combination therapies to enhance the effectiveness of other anticancer agents. Primarily a tool compound in preclinical studies, not approved for clinical use.